← Eichor
Study identifier: NCT05039411 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease

Condition: Perianal Fistula Due to Crohn's Disease · Fistula in Ano  ·  Sponsor: CryoCord Sdn Bhd

PhasePhase 1
Planned participants5
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Objectives: Primary: To demonstrate the safety of allogeneic UC-MSCs administered by injection for complex perianal fistulas in patients with Crohn's disease Secondary: To determine the efficacy of a single/multiple allogeneic UC-MSCs injection in improving complex perianal fistula complications and (re-epithelialization of the external openings).

This description comes directly from the study's public registry record.

Talk to the study team

April Camilla Roslani, Prof. Dr.  ·  +603-7949 2050  ·  april@ummc.edu.my

Always discuss trial participation with your own doctor first.

Locations (1)

University of Malaya Medical CentreKuala Lumpur, MalaysiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05039411